The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder

Biological Psychiatry

Volumn 64, Issue 7, 2008, Pages 636-639

  DeVito, Elise E ^a,b   Blackwell, Andrew D ^a,b   Kent, Lindsey ^a   Ersche, Karen D ^a,b   Clark, Luke ^b   Salmond, Claire H ^a,b   Dezsery, Anna Maria ^a   Sahakian, Barbara J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Cambridge Gamble Task (CGT); decision making; methylphenidate (MPH)

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECISION MAKING; DISRUPTIVE BEHAVIOR; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; MALE; PARENT; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; TASK PERFORMANCE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DECISION MAKING; GAMBLING; HUMANS; MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS;

EID: 50849091265     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.04.017     Document Type: Article

References (20)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Castellanos F.X., and Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nat Rev Neurosci 3 (2002) 617-628
3. Clark L., Bechara A., Damasio H., Aitken M.R., Sahakian B.J., and Robbins T.W. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 131 (2008) 1311-1322
4. Toplak M.E., Jain U., and Tannock R. Executive and motivational processes in adolescents with attention-deficit-hyperactivity disorder (ADHD). Behav Brain Funct 1 (2005) 8
5. Pietrzak R.H., Mollica C.M., Maruff P., and Snyder P.J. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 30 (2006) 1225-1245
6. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60 (2006) 1111-1120
7. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology 20 (1999) 322-339
8. Yurgelun-Todd D. Emotional and cognitive changes during adolescence. Curr Opin Neurobiol 17 (2007) 251-257
9. Volkow N.D., Fowler J.S., Wang G., Ding Y., and Gatley S.J. Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord 6 (2002) S31-S43
10. Wood A., Kroll L., Moore A., and Harrington R. Properties of the mood and feelings questionnaire in adolescent psychiatric outpatients: A research note. J Child Psychol Psychiatry 36 (1995) 327-334
11. Achenbach T.M. Integrative Guide to the 1991 CBCL/4-18, YSR, and TRF Profiles (1991), University of Vermont, Department of Psychology, Burlington, VT
12. Conners C. Conners Rating Scales: CPRS-39, CTRS-39 (1989), Multi-Health Systems, Inc, North Tonawanda, NY
13. Bond A.J., James D.C., and Lader M.H. Physiological and psychological measures in anxious patients. Psychol Med 4 (1974) 364-373
14. Deakin J., Aitken M., Robbins T., and Sahakian B.J. Risk taking during decision-making in normal volunteers changes with age. J Int Neuropsychol Soc 10 (2004) 590-598
15. Dunlap W.P., Cortina J.M., Vaslow J.B., and Burke M.J. Meta-analysis of experiments with matched groups or repeated measures designs. Psychol Methods 1 (1996) 170-177
16. Rahman S., Robbins T.W., Hodges J.R., Mehta M.A., Nestor P.J., Clark L., and Sahakian B.J. Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology 31 (2006) 651-658
17. Solanto M.V., Abikoff H., Sonuga-Barke E., Schachar R., Logan G.D., Wigal T., et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 29 (2001) 215-228
18. Boyer T.W. Decision-making processes: Sensitivity to sequentially experienced outcome probabilities. J Exp Child Psychol 97 (2007) 28-43
19. Huizenga H.M., Crone E.A., and Jansen B.J. Decision-making in healthy children, adolescents and adults explained by the use of increasingly complex proportional reasoning rules. Dev Sci 10 (2007) 814-825
20. Shaw P., Eckstrand K., Sharp W., Blumenthal J., Lerch J.P., Greenstein D., et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A 104 (2007) 19649-19654